Patents Assigned to TiGenix, SA
  • Method of treating graft versus host disease using adipose derived mesenchymal stem cells
    Patent number: 8440177
    Abstract: The present invention relates to the use of a particular type of adipose tissue derived mesenchymal stem cells (AD-MSCs), which exert immunosuppressive properties, in the manufacture of a pharmaceutical composition for the prevention and treatment of the graft-versus-host disease (GVHD) produced after allogeneic hematopoietic stem cell transplantation.
    Type: Grant
    Filed: December 7, 2006
    Date of Patent: May 14, 2013
    Assignees: Centro de Investigaciones Energéticas, Medioambientales y Technológicas, TiGenix, SA
    Inventors: Manuel Angel González De La Peña, Dirk Büscher, Aitor Beraza Pérez, Juan Bueren Roncero, Rosa Maria Yanez González, Maria Lamana Luzuriaga